ACI vs EPIGRAL: Stock Comparison

Archean Chemical Industries Limited vs Epigral Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Archean Chemical Industries Limited is the larger company by market capitalisation. Archean Chemical Industries Limited shows lower leverage, while Epigral Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Archean Chemical Industries Limited and Epigral Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ACI is more favourable on 1 of 13 scored metrics and EPIGRAL on 12These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ACI is the larger company
₹6,858 Cr vs ₹5,036 Cr
P/E Ratio
EPIGRAL has a lower P/E
15.04x vs 65.22x
P/B Ratio
EPIGRAL has a lower P/B
2.25x vs 3.56x
EPS
EPIGRAL has higher earnings per share
₹75.27 vs ₹8.65
Dividend Yield
EPIGRAL has a higher dividend yield
0.43% vs 0.42%
Revenue Growth (TTM YoY)
EPIGRAL has faster revenue growth
17.3% vs -12.9%
EPS Growth (TTM YoY)
EPIGRAL has faster EPS growth
-6.8% vs -73.1%
Qtr Sales Growth
EPIGRAL has stronger quarterly sales growth
17.3% vs -12.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACIEPIGRAL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricACIEPIGRAL
Live Price₹554.85₹1,162.7
Day Change0.27%0.93%
Volume1.56 L3.02 L
52-Week High₹727.6₹2,114
52-Week Low₹483₹807
Distance from 52W High-23.74%-45%

Valuation

MetricACIEPIGRAL
Market Cap₹6,858 Cr₹5,036 Cr
P/E Ratio65.22x15.04x
P/B Ratio3.56x2.25x
EPS₹8.65₹75.27
Book Value₹156.68₹514.92
Dividend Yield0.42%0.43%

Growth

MetricACIEPIGRAL
Revenue Growth (TTM YoY)-12.9%17.3%
EPS Growth (TTM YoY)-73.1%-6.8%
Qtr Sales Growth-12.9%17.3%
Qtr Profit Growth-74.9%-6.84%

Profitability & Leverage

MetricACIEPIGRAL
ROE5.42%16%
ROCE7.41%15.5%
Net Margin9.84%13.14%
Operating Margin22.1%22.4%
Debt to Equity0.24x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricACIEPIGRAL
Promoter Holding53.43%68.83%
FII Holding11% 0.09 pp1.03% 0.51 pp
DII Holding24.18% 1.64 pp5.56% 0.66 pp
Public Holding11.39% 1.73 pp24.55% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Archean Chemical Industries Limited and Epigral Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.